PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Use of antidepressant does not improve symptoms from stomach disorder

2013-12-27
(Press-News.org) Contact information: Kathleen Duffy
Kathleen.Duffy@tuhs.temple.edu
267-800-4359
The JAMA Network Journals
Use of antidepressant does not improve symptoms from stomach disorder Among patients with idiopathic (of unknown cause) gastroparesis, use of the antidepressant nortriptyline compared with placebo for 15 weeks did not result in improvement in overall symptoms, according to a study appearing in the December 25 issue of JAMA. Gastroparesis is a disease of the muscles of the stomach or the nerves controlling the muscles that causes the muscles to stop working, which can result in inadequate grinding of food by the stomach and poor emptying of food from the stomach into the intestine.

Gastroparesis remains a challenging syndrome to manage, with few effective treatments and a lack of rigorously controlled trials. One possible approach to treatment is based on the hypothesis that some of the symptoms (e.g., nausea, pain) arise because of changes in certain nerves. Tricyclic antidepressants are a category of drug often used to treat refractory (not yielding readily to treatment) symptoms of nausea, vomiting, and abdominal pain, according to background information in the article.

Henry P. Parkman, M.D., of Temple University, Philadelphia, and colleagues randomized 130 patients with idiopathic gastroparesis to nortriptyline (n = 65) or placebo (n = 65) to determine whether treatment with the tricyclic antidepressant nortriptyline would result in improvement of symptoms. Study drug dose was increased at 3-week intervals. The primary outcome measure was a decrease in the patient's Gastroparesis Cardinal Symptom Index (GCSI) score of at least 50 percent on 2 consecutive visits during 15 weeks of treatment.

The researchers found that the proportion of patients experiencing symptomatic improvement on 2 visits did not differ between the treatment groups: 15 (23 percent) in the nortriptyline group vs. 14 (21 percent) in the placebo group. There were also no treatment group differences in measures of nausea, fullness or early satiety, or bloating. Treatment was stopped more often in the nortriptyline group (29 percent) than in the placebo group (9 percent), but numbers of adverse events were not different.

"Our results raise general doubts about the utility of tricyclic antidepressants in low doses as a strategy for the treatment of idiopathic gastroparesis," the authors conclude.

###

(doi:10.l001/jama.2013.282833; Available pre-embargo to the media at http://media.jamanetwork.com)

Editor's Note: This trial, from the Gastroparesis Clinical Research Consortium, is supported by National Institute of Diabetes and Digestive and Kidney Diseases grants. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, etc.

END



ELSE PRESS RELEASES FROM THIS DATE:

Nonsteroidal anti-inflammatory agent slows rate of progression of neurodegenerative disease

2013-12-27
Nonsteroidal anti-inflammatory agent slows rate of progression of neurodegenerative disease Among patients with familial amyloid polyneuropathy, a lethal, genetic neurodegenerative disease, use of the nonsteroidal anti-inflammatory agent diflunisal compared ...

Prolonged exposure therapy found beneficial in treating adolescent girls with PTSD

2013-12-27
Prolonged exposure therapy found beneficial in treating adolescent girls with PTSD (PHILADELPHIA) – Researchers at Penn Medicine report in the December 25 issue of JAMA that a modified form of prolonged exposure therapy ...

Antidepressants for bipolar disorder

2013-12-27
Antidepressants for bipolar disorder The use of antidepressants in the treatment of bipolar disorder remains controversial. Some studies and treatment guidelines suggest that antidepressant treatment for bipolar disorder may have the potential to increase the manic ...

NASA sees the last of Cyclone Bruce in Southern Indian Ocean

2013-12-27
NASA sees the last of Cyclone Bruce in Southern Indian Ocean Tropical Cyclone Bruce is winding down in the Southern Indian Ocean as wind shear and cooler waters affect the storm. NASA's Aqua satellite flew over Bruce on December 24 and showed that wind shear is having ...

Kinect-based virtual reality training promotes brain reorganization after stroke

2013-12-27
Kinect-based virtual reality training promotes brain reorganization after stroke The Kinect-based virtual reality system for the Xbox 360 enables users to control and interact with the game console without the need to touch a game controller, and provides rehabilitation ...

Activating P300 protein contributes to repair of hippocampal neuronal DNA injuries

2013-12-27
Activating P300 protein contributes to repair of hippocampal neuronal DNA injuries Various medications have been developed to treat neurodegenerative disorders, and drugs without significant side effects are gaining widespread interest such disorders. Brain Research ...

Epigenetics enigma resolved

2013-12-27
Epigenetics enigma resolved First structure of enzyme that removes methylation Scientists have obtained the first detailed molecular structure of a member of the Tet family of enzymes. The finding is important for the field of epigenetics because Tet enzymes chemically ...

Researchers complete a milestone in defining the genetic basis of rheumatoid arthritis

2013-12-27
Researchers complete a milestone in defining the genetic basis of rheumatoid arthritis MANHASSET, NY – An international group of investigators has discovered new genes, pathways and cell types that are involved in inherited susceptibility to rheumatoid ...

International team completes systematic, genomic study of cervical cancer

2013-12-27
International team completes systematic, genomic study of cervical cancer Findings point to potential therapeutics, shed light on HPV role Researchers from the Boston area, Mexico, and Norway have completed a comprehensive genomic analysis of cervical ...

New genetic risk factor for type 2 diabetes revealed

2013-12-27
New genetic risk factor for type 2 diabetes revealed Samples from Mexican, Latin American populations shed light on disease Cambridge and Boston, MA; Los Angeles, CA; Mexico City, Mexico. Wed. December 25, 2013 – An international team of researchers ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Use of antidepressant does not improve symptoms from stomach disorder